The effects of selective brain hypothermia on intracerebral hemorrhage in rats
The effects of selective brain hypothermia on intracerebral hemorrhage in rats
复制标题
DOI:
10.1016/j.expneurol.2007.08.018
复制
发表时间:
2007-12-01
影响因子:
5.3
通讯作者:
Colbourne, Frederick
中科院分区:
文献类型:
--
作者:
Fingas, Matthew;Clark, Darren L.;Colbourne, Frederick
Prolonged hypothermia effectively treats global cerebral ischemic injury in animal models as well as in cardiac arrest victims. Furthermore, clinical trials, based upon encouraging animal findings, are underway to assess efficacy in ischemic stroke. Intracerebral hemorrhage (ICH) is a more devastating stroke, but one that shares mechanisms of injury with ischemia. Accordingly, ICH may be amenable to hypothermia treatment. In this study we tested whether selective brain hypothermia improves outcome after an ICH in rats created by infusing 100 mu L of autologous whole blood into the striatum. Striatal hypothermia (similar to 32 degrees C) was induced with a novel method (implanted cooling coil) that does not cause systemic cooling, thereby providing a safer and potentially more effective treatment for stroke than systemic hypothermia. Edema occurred for 4 days after ICH, but it peaked at 3 days (similar to 5%). At this time it was significantly reduced (to similar to 2%) by cooling starting 1 h after ICH (3 day duration). Next, we determined whether 1 and 12 h delayed cooling treatments (4 day duration) would lessen functional impairment and lesion size. Untreated (nonnothermic) ICH resulted in significant forelimb use asymmetry, as well as deficits in walking and skilled reaching. These deficits were unaffected by hypothermia, as was the volume of tissue lost (similar to 20 mm(3)) at 1 month. Thus, attenuated edema did not result in behavioral or histological benefit. In conclusion, while additional research with alternative cooling protocols and ICH models are required, these findings suggest that while hypothermia lessens edema, it will not be directly neuroprotective after ICH. (c) 2007 Elsevier Inc. All rights reserved.